Teva Pharmaceutical has received FDA approval to market the generic version of Roche‘s Kytril (granisetron hydrochloride) 1mg/mL injection and 1mg tablets. Granisetron hydrochloride is indicated for the prevention of nausea and vomiting associated with chemotherapy and for the prevention and treatment of post-op nausea and vomiting.

For more information call (215) 591-3000 or visit